72
Views
8
CrossRef citations to date
0
Altmetric
Drug Profile

Lubiprostone for chronic idiopathic constipation and irritable bowel syndrome with constipation

&
Pages 497-508 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Marcella Pesce, Maria Giovanna Puoti, Anna Rybak, Marta Andreozzi, Eugenia Bruzzese, Giovanni Sarnelli & Osvaldo Borrelli. (2022) Pharmacological interventions for pediatric irritable bowel syndrome. Expert Opinion on Pharmacotherapy 23:1, pages 91-103.
Read now
Emanuel Raschi & Fabrizio De Ponti. (2014) Lubiprostone: pharmacokinetic, pharmacodynamic, safety and regulatory aspects in the treatment of constipation-predominant irritable bowel syndrome. Expert Opinion on Drug Metabolism & Toxicology 10:2, pages 293-305.
Read now
Shailendra Kapoor. (2010) Emerging New Therapeutic Options for the Management of Opioid Induced Constipation. Journal of Pain & Palliative Care Pharmacotherapy 24:1, pages 98-99.
Read now
Laura Diego, Rabia Atayee, Pieter Helmons & Charles F von Gunten. (2009) Methylnaltrexone: a novel approach for the management of opioid-induced constipation in patients with advanced illness. Expert Review of Gastroenterology & Hepatology 3:5, pages 473-485.
Read now
Michael D Crowell, Lucinda A Harris, Tisha N Lunsford & John K DiBaise. (2009) Emerging drugs for chronic constipation. Expert Opinion on Emerging Drugs 14:3, pages 493-504.
Read now

Articles from other publishers (3)

Miguel Saps & Adrian Miranda. 2017. Gastrointestinal Pharmacology. Gastrointestinal Pharmacology 147 176 .
Stacy Menees, Richard Saad & William D. Chey. (2012) Agents that act luminally to treat diarrhoea and constipation. Nature Reviews Gastroenterology & Hepatology 9:11, pages 661-674.
Crossref
Gerhild Becker & Hubert E Blum. (2009) Novel opioid antagonists for opioid-induced bowel dysfunction and postoperative ileus. The Lancet 373:9670, pages 1198-1206.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.